Chemoinformaics analysis of Sanguinarium Chloride
| Molecular Weight | 367.788 | nRot | 0 |
| Heavy Atom Molecular Weight | 353.676 | nRig | 29 |
| Exact Molecular Weight | 367.061 | nRing | 6 |
| Solubility: LogS | -8.561 | nHRing | 3 |
| Solubility: LogP | 5.224 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 4 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 3 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 21 |
| nHA | 4 | APOL | 49.2231 |
| nHD | 0 | BPOL | 22.6989 |
| QED | 0.365 |
| Synth | 2.899 |
| Natural Product Likeliness | 1.059 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 1 |
| HIA | 0.002 |
| CACO-2 | -5.062 |
| MDCK | 0.0000643 |
| BBB | 0.472 |
| PPB | 0.815838 |
| VDSS | 1.15 |
| FU | 0.0141868 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.198 |
| CYP2c19-inh | 0.888 |
| CYP2c19-sub | 0.605 |
| CYP2c9-inh | 0.079 |
| CYP2c9-sub | 0.842 |
| CYP2d6-inh | 0.987 |
| CYP2d6-sub | 0.939 |
| CYP3a4-inh | 0.793 |
| CYP3a4-sub | 0.106 |
| CL | 16.562 |
| T12 | 0.128 |
| hERG | 0.037 |
| Ames | 0.954 |
| ROA | 0.047 |
| SkinSen | 0.772 |
| Carcinogencity | 0.966 |
| EI | 0.87 |
| Respiratory | 0.865 |
| NR-Aromatase | 0.635 |
| Antiviral | Yes |
| Prediction | 0.64897 |